Literature DB >> 24366030

Stable RNA interference rules for silencing.

Christof Fellmann1, Scott W Lowe2.   

Abstract

RNA interference has become an indispensable tool for loss-of-function studies across eukaryotes. By enabling stable and reversible gene silencing, shRNAs provide a means to study long-term phenotypes, perform pool-based forward genetic screens and examine the consequences of temporary target inhibition in vivo. However, efficient implementation in vertebrate systems has been hindered by technical difficulties affecting potency and specificity. Focusing on these issues, we analyse current strategies to obtain maximal knockdown with minimal off-target effects.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24366030      PMCID: PMC4001088          DOI: 10.1038/ncb2895

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  137 in total

1.  MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms.

Authors:  Yan Zeng; Rui Yi; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-05       Impact factor: 11.205

2.  MicroRNA genes are transcribed by RNA polymerase II.

Authors:  Yoontae Lee; Minju Kim; Jinju Han; Kyu-Hyun Yeom; Sanghyuk Lee; Sung Hee Baek; V Narry Kim
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

3.  A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells.

Authors:  Frank Stegmeier; Guang Hu; Richard J Rickles; Gregory J Hannon; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-01       Impact factor: 11.205

4.  Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites.

Authors:  Rickard Sandberg; Joel R Neilson; Arup Sarma; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2008-06-20       Impact factor: 47.728

5.  Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal.

Authors:  Yue Wang; Zhenyu Xu; Junfeng Jiang; Chen Xu; Jiuhong Kang; Lei Xiao; Minjuan Wu; Jun Xiong; Xiaocan Guo; Houqi Liu
Journal:  Dev Cell       Date:  2013-03-28       Impact factor: 12.270

6.  Gene regulation for higher cells: a theory.

Authors:  R J Britten; E H Davidson
Journal:  Science       Date:  1969-07-25       Impact factor: 47.728

7.  Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation.

Authors:  Tim A Rand; Sean Petersen; Fenghe Du; Xiaodong Wang
Journal:  Cell       Date:  2005-11-03       Impact factor: 41.582

8.  Generation of shRNA transgenic mice.

Authors:  Christiane Hitz; Patricia Steuber-Buchberger; Sabit Delic; Wolfgang Wurst; Ralf Kühn
Journal:  Methods Mol Biol       Date:  2009

9.  Life in the fast lane: mammalian disease models in the genomics era.

Authors:  Lukas E Dow; Scott W Lowe
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

10.  A rapid and scalable system for studying gene function in mice using conditional RNA interference.

Authors:  Prem K Premsrirut; Lukas E Dow; Sang Yong Kim; Matthew Camiolo; Colin D Malone; Cornelius Miething; Claudio Scuoppo; Johannes Zuber; Ross A Dickins; Scott C Kogan; Kenneth R Shroyer; Raffaella Sordella; Gregory J Hannon; Scott W Lowe
Journal:  Cell       Date:  2011-04-01       Impact factor: 41.582

View more
  67 in total

Review 1.  In vivo RNAi screens: concepts and applications.

Authors:  Shane Crotty; Matthew E Pipkin
Journal:  Trends Immunol       Date:  2015-04-27       Impact factor: 16.687

2.  Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions.

Authors:  Kristin Derlig; Andreas Gießl; Johann Helmut Brandstätter; Ralf Enz; Regina Dahlhaus
Journal:  J Vis Exp       Date:  2016-04-21       Impact factor: 1.355

Review 3.  Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR.

Authors:  Michael Boettcher; Michael T McManus
Journal:  Mol Cell       Date:  2015-05-21       Impact factor: 17.970

4.  Translational value of mouse models in oncology drug development.

Authors:  Stephen E Gould; Melissa R Junttila; Frederic J de Sauvage
Journal:  Nat Med       Date:  2015-05       Impact factor: 53.440

Review 5.  Emerging strategies for RNA interference (RNAi) applications in insects.

Authors:  Raja Sekhar Nandety; Yen-Wen Kuo; Shahideh Nouri; Bryce W Falk
Journal:  Bioengineered       Date:  2014-12-31       Impact factor: 3.269

Review 6.  Crop resistant starch and genetic improvement: a review of recent advances.

Authors:  Jian Xia; Dong Zhu; Ruomei Wang; Yue Cui; Yueming Yan
Journal:  Theor Appl Genet       Date:  2018-10-29       Impact factor: 5.699

Review 7.  MicroRNA mediated regulation of immunity against gram-negative bacteria.

Authors:  Jonathon Keck; Rishein Gupta; Lane K Christenson; Bernard P Arulanandam
Journal:  Int Rev Immunol       Date:  2017-08-11       Impact factor: 5.311

8.  Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems.

Authors:  Susanne R Youngren-Ortiz; Nishant S Gandhi; Laura España-Serrano; Mahavir B Chougule
Journal:  Kona       Date:  2015-09-30       Impact factor: 2.897

9.  Knockdown of β-catenin by siRNA influences proliferation, apoptosis and invasion of the colon cancer cell line SW480.

Authors:  Kui Li; Zhong-Yin Zhou; Pan-Pan Ji; He-Sheng Luo
Journal:  Oncol Lett       Date:  2016-04-20       Impact factor: 2.967

Review 10.  Cornerstones of CRISPR-Cas in drug discovery and therapy.

Authors:  Christof Fellmann; Benjamin G Gowen; Pei-Chun Lin; Jennifer A Doudna; Jacob E Corn
Journal:  Nat Rev Drug Discov       Date:  2016-12-23       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.